van Elsas et al., 1996 - Google Patents
Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A* 0201‐binding peptides from the Melan‐A/MART …van Elsas et al., 1996
- Document ID
- 11650773971006845222
- Author
- van Elsas A
- van der Burg S
- van der Minne C
- Borghi M
- Mourer J
- Melief C
- Schrier P
- Publication year
- Publication venue
- European journal of immunology
External Links
Snippet
The melanoma antigen Melan‐A/MART‐1 was screened for the presence of potential HLA‐ A* 0201‐binding cytotoxic T lymphocytes (CTL) epitopes. The immunodominant nonamer epitope AAGIGILTV demonstrated weak binding to T2 but a significant half‐life of binding to …
- 210000000400 T-Lymphocytes, Cytotoxic 0 title abstract description 102
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| van Elsas et al. | Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A* 0201‐binding peptides from the Melan‐A/MART‐1 self antigen | |
| JP5627180B2 (en) | Tumor-associated peptide that binds to human leukocyte antibody (HLA) class II molecules indiscriminately | |
| Bruggen et al. | Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601 | |
| Herman et al. | A peptide encoded by the human MAGE3 gene and presented by HLA-1344 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3 | |
| Houbiers et al. | In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53 | |
| Parkhurst et al. | Identification of a shared HLA-A* 0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2) | |
| EP1012283B1 (en) | Mage-3 peptides presented by hla class ii molecules | |
| KR101391561B1 (en) | -*3303 1 hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same | |
| ES2317378T3 (en) | TUMOR ASSOCIATED PEPTIDES UNITED TO MHC MOLECULES. | |
| KR101216655B1 (en) | PROTEINS BELONGING TO THE Bcl-2 FAMILY AND FRAGMENTS THEREOF, AND THEIR USE IN CANCER PATIENTS | |
| EP2043679A2 (en) | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer | |
| Visseren et al. | Identification of HLA‐A* 0201‐restricted CTL epitopes encoded by the tumor‐specific MAGE‐2 gene product | |
| US20110070253A1 (en) | Tumour-associated peptides binding to mhc molecules | |
| JP2008514208A (en) | Immunogenic T helper epitopes from human tumor antigens and methods of immunotherapy using said epitopes | |
| WO1999050637A2 (en) | Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof | |
| US20050267020A1 (en) | Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same | |
| Naota et al. | Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells | |
| CA2423481C (en) | Isolated peptides which bind to hla-c molecules and uses thereof | |
| JP2002502224A (en) | Methods for identifying individuals with cellular abnormalities | |
| JP5736333B2 (en) | Tumor-associated peptide that binds to human leukocyte antibody (HLA) class II molecules indiscriminately | |
| JP5736334B2 (en) | Tumor-associated peptide that binds to human leukocyte antibody (HLA) class II molecules indiscriminately | |
| JP3840268B2 (en) | Cytotoxic T lymphocytes | |
| Visser et al. | Molecular characterization of melanoma-derived antigens | |
| EP1395276A1 (en) | Structurally modified peptides and uses thereof | |
| Houbiers et al. | Heidelberg zyxwvutsrqponmlkj |